| 摘要 |
<p>The invention relates to a stable topotecan pharmaceutical composition in the form of a gelatin capsule. The invention specifically provides a hydrophobic matrix for formulation with topotecan HC1 that is dispersed so as to minimize any chemical reaction between the active drug, the excipients and ambient moisture.</p> |
